SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MGI Pharma MOGN New patents, anti cancer
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1826 45 0 MOGN
Emcee:  Mark Oliver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
751 Assuming we get a European partner in April,is that going to move MOGN to $12?adam hefian-2/28/1998
750 V1, I was moved by your post sharing the story of your father's battle witDavid Cathcart-2/28/1998
749 I just bought some more. :0) <eom>astro-2/27/1998
748 Peter, Thanks for your efforts in estimating the prospects of MGI-114 in your David Cathcart-2/27/1998
747 Peter Effects on DNA integrity and apoptosis induction by a novel antitumor seseminole-2/26/1998
746 V1, <<Numerous compounds have shown great promise in Xenotransplanted tuDavid Cathcart-2/25/1998
745 Grammy, Thanks. No need to dig out the actual purchase date - just wanted to mBiomaven-2/25/1998
744 David Thanks for your quick response. I found on Yahoo a note that seems to sseminole-2/25/1998
743 Richard, As I have posted before, the new Director Joseph Frelinghuysen boughtDavid Cathcart-2/25/1998
742 Peter, Yes, that was the filing date and not the purchase date. The purcDavid Graham-2/25/1998
741 Grammy, <<On 1/5/98 8,000 shares were registered for a purchase to a dirBiomaven-2/25/1998
740 Richard, On 1/5/98 8,000 shares were registered for a purchase to a direcDavid Graham-2/25/1998
739 MGI Fans Does anyone subscribe or have access to current insider stock purchasseminole-2/25/1998
738 Richard, Clearly the volume is building which is good. I think investors are tVector1-2/23/1998
737 Vector1 How do you feel about volume change before price change? quicken.excitseminole-2/23/1998
736 <<I hate animal studies, but they provide important information on the tyVector1-2/23/1998
735 Peter, I think your guesstimate analysis is as good as any and fairly consistenVector1-2/23/1998
734 Peter The back of my ticket says 50/50. richardseminole-2/23/1998
733 Richard: Remember that the 2% number was the final product of a series of wildBiomaven-2/23/1998
732 Vector1 Thanks for the reference. The mouse model also concerns me. I am a chseminole-2/23/1998
731 Peter Wow, 2% chance to be a monster drug. I like those odds. I remember ten seminole-2/23/1998
730 V1: Thanks for the reference - I'll get hold of it and see whether it servBiomaven-2/23/1998
729 <<Could you point us to some actual examples? Were the failures because oVector1-2/22/1998
728 V1: Here's a new (I think) abstract on MG-114's mode of action: EffecBiomaven-2/21/1998
727 david, i know a little about blitzer at marion labls but could you or someone pthe eagle-2/21/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News